valproic acid has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, MP | 1 |
| Bhowmik, M; Saini, N; Vohora, D | 1 |
2 other study(ies) available for valproic acid and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
| Article | Year |
|---|---|
What do insulin, estrogen, valproic acid, and TDZD-8 have in common?
Topics: Animals; Estrogens; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Insulin; Rats; Thiadiazoles; Valproic Acid | 2005 |
Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice.
Topics: Animals; Anticonvulsants; Benzofurans; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hippocampus; Histamine H3 Antagonists; Kainic Acid; Male; Mice; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Protein Kinase Inhibitors; Pyrrolidines; Random Allocation; Seizures; Thiadiazoles; Valproic Acid | 2014 |